Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1106 results

Novo Nordisk posts strong results, reassures with guidance

Novo Nordisk posts strong results, reassures with guidance

30-10-2014

Global diabetes care giant, Denmark’s Novo Nordisk saw its shares gain 4% to 265.80 Danish kroner this…

DiabetesFinancialNovo NordiskPharmaceutical

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

NicOx's acquisitions pay off as sales rocket to 4 million euros in third quarter

30-10-2014

French pharma company NicOx has achieved sales of 4 million euros ($5 million) in the third quarter of…

FinancialFranceNicOxOphthalmicsPharmaceutical

Bayer sees strong third-qtr sales and earnings growth

Bayer sees strong third-qtr sales and earnings growth

30-10-2014

Reporting third-quarter 2014 financials this morning, German pharma major Bayer (BAYN: DE) said group…

BayerFinancialPharmaceutical

Specialty care and Somatuline drive Ipsen's positive third quarter financials

Specialty care and Somatuline drive Ipsen's positive third quarter financials

29-10-2014

French drugmaker Ipsen has reported sales of 329 million euros ($419.1 million) for the third quarter…

DysportFinancialFranceIpsenPharmaceuticalSomatuline

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Recordati reports strong earnings growth for first nine months of 2014

28-10-2014

Italian pharma company Recordati has reported a strong set of financials for the first three-quarters…

FinancialPharmaceuticalRecordati

Novartis’ strong third-qtr boosted by sale of Idenix stake

Novartis’ strong third-qtr boosted by sale of Idenix stake

28-10-2014

Swiss pharma major Novartis this morning reported that sales for the third quarter of 2014 rose 4% to…

AlconFinancialNovartisPharmaceuticalSandozSwitzerland

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

Merck & Co third-qtr disappoints, as earnings plunge

Merck & Co third-qtr disappoints, as earnings plunge

27-10-2014

US pharma giant Merck & Co (NYSE: MRK) posted third-quarter 2014 financial results today, showing that…

FinancialKeytrudaMerck & CoOncologyPharmaceuticalRegulationUSA

Australian PBS listing for Kalydeco and Soliris

Australian PBS listing for Kalydeco and Soliris

27-10-2014

Kalydeco (ivacaftor) and Soliris (eculizumab) – new treatments for cystic fibrosis (CF) and hemolytic…

Alexion PharmaceuticalsAustraliaFinancialHealthcareKalydecoPharmaceuticalRare diseasesSolirisVertex Pharmaceuticals

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Bristol-Myers Squibb third-qtr earnings top expectations

Bristol-Myers Squibb third-qtr earnings top expectations

25-10-2014

US pharma major Bristol-Myers Squib posted a strong set of financials for the third quarter of 2014,…

Bristol-Myers SquibbFinancialPharmaceutical

Shire posts sharp rises in sales and earnings for third-qtr

Shire posts sharp rises in sales and earnings for third-qtr

24-10-2014

Ireland-headquartered Shire has delivered a strong set of financials for the third-quarter of 2014, validating…

AbbVieAmerican depositary shareFinancialPharmaceuticalShire

VIDEO: Chief executive Sir Andrew Witty discusses GSK's results

VIDEO: Chief executive Sir Andrew Witty discusses GSK's results

24-10-2014

Chief executive of UK pharma giant GlaxoSmithKline Sir Andrew Witty has commented on the company's third…

FinancialGlaxoSmithKlinePharmaceuticalPharmaceutical industryUK

Experts' comments on GSK floating its HIV business

Experts' comments on GSK floating its HIV business

24-10-2014

The announcement this week by UK pharma giant GlaxoSmithKline that it is mulling a possible initial public…

FinancialGlaxoSmithKlinePharmaceuticalViiV Healthcare

Eli Lilly hit by patent expirations on Cymbalta and Evista as third-qtr profit drops of 58%

Eli Lilly hit by patent expirations on Cymbalta and Evista as third-qtr profit drops of 58%

23-10-2014

US drug major Eli Lilly reported third quarter 2014 results that showed how badly the company has been…

CymbaltaEli LillyEli Lilly and CompanyEvistaFinancialPharmaceuticalUnited StatesUSA

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

Abbott raises midpoint of EPS guidance and sees shares rise as quarterly profit exceeds forecast

22-10-2014

Shares of US health care company Abbott Laboratories rose slightly in the premarket trading period following…

Abbott LaboratoriesFinancialPharmaceuticalUnited StatesUSA

GlaxoSmithKline’s third-qtr results not as bad as expected

GlaxoSmithKline’s third-qtr results not as bad as expected

22-10-2014

UK pharma giant GlaxoSmithKline has reported a downturn in both sales and profits for the third quarter…

FinancialGlaxoSmithKlinePharmaceuticalThomson ReutersUKViiV Healthcare

New angel investment initiative to boost funding for UK bioscience businesses

New angel investment initiative to boost funding for UK bioscience businesses

22-10-2014

Emerging bioscience companies in the UK will have access to new sources of funding as a result of an…

FinancialLondon Business AngelsPharmaceuticalUKUnited Kingdom

Roche to invest billions in new R&D facility and Basel updates

Roche to invest billions in new R&D facility and Basel updates

22-10-2014

Swiss pharma major Roche says it will invest 3 billion Swiss francs ($3.2 billion) in new research infrastructure…

FinancialGeography of EuropePharmaceuticalRocheSwitzerland

Currency restrictions may result in collapse of Ukrainian pharmaceutical market

21-10-2014

Leading Ukrainian pharmaceutical producers and importers have sent an official letter to the national…

FinancialPharmaceuticalPoliticsUkraine

Shire to receive $1.635 billion break fee from AbbVie

Shire to receive $1.635 billion break fee from AbbVie

21-10-2014

The board of Ireland-headquartered drugmaker Shire has said there is now no realistic prospect of AbbVie…

AbbVieBusiness FinanceCity Code on Takeovers and MergersFinancialMergers & AcquisitionsMergers and acquisitionsPharmaceuticalShireUSA

Scientists say USA’s national Alzheimer's plan milestones must be strengthened to meet goal by 2025

20-10-2014

The US government has initiated a major effort to prevent and effectively treat Alzheimer's disease by…

FinancialNeurologicalPharmaceuticalResearchUSA

Baxter third-qtr earnings hit by costs, but sales rise

16-10-2014

US health care product company Baxter International today reported a 14% drop in net income of $468 million…

Baxter InternationalFinancialPharmaceutical

1 to 25 of 1106 results

Parexel

Parexel

Back to top